Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lluch

Showing results (31-40 of 186) with videos related to

Pageof 19
Sort By:
Medicina Clinica|January 22, 2004
[Epidemiological study of the GEICAM group about breast cancer in Spain (1990-1993): El Alamo project]Miguel Martín, Antonio Llombart-Cussac, Ana Lluch, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2018
In Reply to Belkacemi and TsoutsouYoussef H Zeidan, Joyce G Habib, Evandro de Azambuja, et al.
Anticancer Research|July 24, 2010
Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancerAntonio Anton, Ana Lluch, Antonio Casado, et al.
The Biochemical Journal|January 8, 2009
Nitration of cathepsin D enhances its proteolytic activity during mammary gland remodelling after lactationRosa Zaragozá, Luis Torres, Concha García, et al.
Critical Reviews in Oncology/Hematology|August 30, 2021
Fertility and breast cancer: A literature review of counseling, preservation options and outcomesSantiago Moragón, Raimondo Di Liello, Begoña Bermejo, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2016
Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor-positive, human epidermal growth factor receptor 2-negative early-stage breast cancerJoan Albanell, Christer Svedman, Joseph Gligorov, et al.
Scientific Reports|October 20, 2019
Acceleration in the DNA methylation age in breast cancer tumours from very young womenSara S Oltra, Maria Peña-Chilet, Kirsty Flower, et al.
Breast Cancer Research and Treatment|May 9, 2008
Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patientsIsabel Chirivella, Begoña Bermejo, Amelia Insa, et al.
Breast (Edinburgh, Scotland)|July 2, 2013
An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancerJose A Pérez-Fidalgo, Pilar Eroles, Jaime Ferrer, et al.
Clinical Breast Cancer|November 26, 2009
Outcome differences between patients with node-negative breast cancer classified according to the st. Gallen risk categoriesIsabel Blancas, Francisco J Gómez, Begoña Bermejo, et al.
Pageof 19

Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
Medicina Clinica|January 22, 2004
[Epidemiological study of the GEICAM group about breast cancer in Spain (1990-1993): El Alamo project]Miguel Martín, Antonio Llombart-Cussac, Ana Lluch, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2018
In Reply to Belkacemi and TsoutsouYoussef H Zeidan, Joyce G Habib, Evandro de Azambuja, et al.
Anticancer Research|July 24, 2010
Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancerAntonio Anton, Ana Lluch, Antonio Casado, et al.
The Biochemical Journal|January 8, 2009
Nitration of cathepsin D enhances its proteolytic activity during mammary gland remodelling after lactationRosa Zaragozá, Luis Torres, Concha García, et al.
Critical Reviews in Oncology/Hematology|August 30, 2021
Fertility and breast cancer: A literature review of counseling, preservation options and outcomesSantiago Moragón, Raimondo Di Liello, Begoña Bermejo, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2016
Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor-positive, human epidermal growth factor receptor 2-negative early-stage breast cancerJoan Albanell, Christer Svedman, Joseph Gligorov, et al.
Scientific Reports|October 20, 2019
Acceleration in the DNA methylation age in breast cancer tumours from very young womenSara S Oltra, Maria Peña-Chilet, Kirsty Flower, et al.
Breast Cancer Research and Treatment|May 9, 2008
Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patientsIsabel Chirivella, Begoña Bermejo, Amelia Insa, et al.
Breast (Edinburgh, Scotland)|July 2, 2013
An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancerJose A Pérez-Fidalgo, Pilar Eroles, Jaime Ferrer, et al.
Clinical Breast Cancer|November 26, 2009
Outcome differences between patients with node-negative breast cancer classified according to the st. Gallen risk categoriesIsabel Blancas, Francisco J Gómez, Begoña Bermejo, et al.
Pageof 19